Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher – Tale of the Tape

The third-largest drugstore chain in the U.S., Rite Aid has seen 5 positive estimate revisions in the last 60 days. The Zacks Consensus Estimate has also moved higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if yesterday’s climb can turn into more strength down the road.

Rite Aid currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Investors interested in Retail-Drug Store stocks may also consider CVS Health Corp. (CVS) which carries the same rank as Rite Aid.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>